Skip to main content
The PRIMED website will be unavailable from Friday, April 19 at 5pm PT/8pm ET to Monday April 22 at 8am PT/11am ET (63 hours). You may encounter errors or may not be able to access the site during this time. Also, you will be unable to log in to the CC's AnVIL Consortium manager web app. We apologize for any inconvenience.

Polygenic Risk Estimation and Validation to ENhance Treatment - Coronary Heart Disease (PREVENT)

As part of the PRIMED consortium, the Mayo team (Iftikhar Kullo, contact PI and Daniel Schaid, multiple PI) will generate PRSs for populations of diverse ancestry using existing and new datasets with genotype and phenotype data for CHD and its risk factors. They will develop statistical methods to account for admixture and ‘local’ ancestry when estimating PRSs in admixed individuals and investigate whether weighting variants by function improves risk prediction. They will integrate PRSs with clinical information to compute absolute risk estimates for individuals from diverse ancestry groups. 

Contact PI
Program Officer
  • Robb Rowley (NIH,  National Institutes of Health)